Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing

by August 15, 2024
August 15, 2024
AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing

The Treasury has reassured that it remains in “positive discussions” with AstraZeneca regarding the pharmaceutical giant’s proposed £450 million vaccine manufacturing facility in northwest England.

However, doubts have emerged following reports that the government is considering reducing its financial support for the project to £40 million—a significant cut from the £65 million reportedly promised by former chancellor Jeremy Hunt.

This investment, along with a separate £200 million expansion of AstraZeneca’s global research and development hub in Cambridge, was highlighted by Hunt in his March budget speech. At the time, he praised AstraZeneca as “one of our greatest life science companies,” led by the “irrepressible” Sir Pascal Soriot.

Although Soriot, AstraZeneca’s CEO, has expressed confidence in UK life sciences, he has also voiced concerns about the country’s business and fiscal environment. Following Labour’s recent election victory, the Treasury, under new Chancellor Rachel Reeves, is reviewing spending decisions made by the previous government, including those related to AstraZeneca’s expansion plans.

Local MP Maria Eagle, whose Liverpool Garston constituency includes the Speke site, is reportedly planning a meeting with the government’s Office for Life Sciences to secure the investment. The Treasury has reaffirmed its commitment to making the UK a global leader in the development and manufacture of innovative medicines and confirmed that discussions with AstraZeneca are ongoing.

AstraZeneca, which recently saw its market value surpass £200 billion, declined to comment on the situation. Last month, Soriot indicated that the company was “absolutely ready to go” with the Speke expansion and expressed hope that the government contract could be finalised soon.

Shadow Secretary of State for Science, Innovation and Technology, Andrew Griffith, expressed disappointment, stating that the Treasury’s actions appear to undermine the UK’s ambitions to become a global science and technology leader. He warned that jeopardising AstraZeneca’s plans could threaten a significant British success story.

Read more:
AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing

0
FacebookTwitterGoogle +Pinterest
previous post
Tata Steel workers and suppliers receive £13.5 million in emergency funding amid Port Talbot restructuring
next post
Iran’s new president asserts right to retaliation in rare phone call with major US ally

You may also like

Clearing the Clutter: Why Efficient Property Clearance is...

May 25, 2025

Lotus accelerates with record 2,200 sports cars produced...

August 10, 2023

Royal Mail faces £100m hit from strikes

August 25, 2022

Sustaining productivity in a world of hybrid work

August 17, 2022

VAT expert calls for reform of “Britain’s most...

March 30, 2023

Inheritance Tax Receipts raise £600 million in a...

May 23, 2023

UK ports demand compensation after Brexit border checks...

May 20, 2025

Capital Gains Tax changes may reveal underpaid tax

September 19, 2023

Multitude of daggers from velvet sheaths are thrown...

October 10, 2022

How Mojo App helps Companies to reach Customers...

January 13, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Friday Feature: Savannah Legacy Academy

      June 27, 2025
    • The Supreme Court Is Right on Reading Opt-Outs, But That’s Not Enough

      June 27, 2025
    • Barrett eviscerates Jackson, Sotomayor takes on a ‘complicit’ court in contentious final opinions

      June 27, 2025
    • Trump would strike Iran ‘without question’ if it restarts nuclear weapons program

      June 27, 2025
    • Florida man indicted for ’86’ posts allegedly threatening to kill Alina Habba

      June 27, 2025
    • Top House Republicans send stern warning to Senate GOP as Trump’s ‘big, beautiful bill’ risks delay

      June 27, 2025

    Categories

    • Business (8,329)
    • Investing (2,079)
    • Politics (15,835)
    • Stocks (3,174)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved